FEATURED NEWS

• HDA Statement on FDA’s Drug Supply Chain Security Act-Related Enforcement Discretion

  October 22, 2020

  In response to the Food and Drug Administration’s (FDA) decision to extend enforcement discretion related to certain Drug Supply Chain Security Act requirements, the Healthcare Distribution Alliance (HDA) released the following statement.

• HDA's PCSC Recognizes Supply Chain Security Leaders

  October 8, 2020

  HDA’s Pharmaceutical Cargo Security Coalition recognized three outstanding supply chain security professionals today through the annual PCSC Awards.

• HDA Releases Policy Principles for COVID-19 Vaccine Distribution

  October 8, 2020

  The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration.

• HDA Announces Robert Mauch and Chad Gielen to Lead Board of Directors

  October 5, 2020

  The Healthcare Distribution Alliance today announces the election of Robert Mauch, PharmD, PhD, EVP and Group President of AmerisourceBergen Corporation, as Chairman of the HDA Board of Directors. Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., will serve as Vice Chairman.

• HDA Statement on FDA Drug Importation Final Rule

  September 25, 2020

  In response to the Food and Drug Administration’s (FDA) final rule permitting prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.